CellaVision
CellaVision AB is a Swedish medical technology company specializing in automated digital microscopy for blood and body fluid analysis. The company develops analyzers, software, and reagents that automate, standardize, and streamline digital hematology processing in medical laboratories. Main revenue drivers include sales of digital microscopy hardware, software licensing, reagent consumables, and maintenance services. CellaVision serves clinical pathology laboratories, hospital diagnostic networks, and commercial laboratory testing facilities globally. The company occupies a globally dominant market position in automated digital cell morphology and hematology diagnostics. Headquartered in Lund, Sweden, CellaVision AB is listed on Nasdaq Stockholm.
13 of the funds FundTelligence covers report a position in CellaVision.
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 13
Funds holding CellaVision
- ODIN Micro Cap — ODIN · 4.8 % (largest positions only, October 2026)
- Case All Star Småbolag — Case · 2.92 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 2.37 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 2.22 % (full portfolio disclosed, June 2026)
- Handelsbanken Microcap Norden — Handelsbanken · 0.72 % (full portfolio disclosed, October 2026)
- SEB Sverigefond Småbolag Chans/Risk — SEB · 0.5 % (full portfolio disclosed, June 2026)
- Nordea Nordic Small Cap — Nordea Funds · 0.29 % (full portfolio disclosed, July 2026)
- Nordea Nordic Small Cap Fund — Nordea Funds · 0.29 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 13 funds holding it.